BioXcel Therapeutics, Inc. BTAI
Set alert
0.07 USD 0.00 0.00%
At close · Sep 4
1.30 +1.23 +1,659.13%
After hours · Sep 4, 4:00 PM ET
0.069 Day range 0.0935
0.30 52-week range 4.17
- YTD
- -95.38%
- 1 year
- -96.36%
- Open
- 0.091
- Prev close
- 0.0739
- Mkt cap
- 16.98M
- Vol
- 47.48M
- Avg vol
- 616.96K
- EPS
- -2.04
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.069
- High
- 0.0935
- Forward P/E
- -0.21
- Beta
- 0.29
- Short ratio
- 0.93
- Inst. own
- 8.76%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 6, 2024
- 50-d avg
- 0.53274
- 200-d avg
- 1.28
- 1y target
- 5.00
Analyst view
Consensus: none
Price target (mean) 5.00 +6665.9% upside
Now 0.0739
- Target (low)
- 1.00
- Target (mean)
- 5.00
- Target (high)
- 7.00
Ratings (0m) 4 3 buy · 1 hold · 0 sell
- Strong buy1
- Buy2
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 5
- 2 months ago 5
- 3 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.31 | -0.31 – -0.31 | -0.76 | +59.2% | 1.24M | +230.4% | 1 |
| Next quarter | -0.45 | -0.45 – -0.45 | -0.87 | +48.3% | 0 | 0.0% | 1 |
| Current year | -1.57 | -1.57 – -1.57 | -6.00 | +73.9% | 3.80M | +175.7% | 1 |
| Next year | -1.36 | -1.54 – -1.04 | -1.57 | +13.6% | 7.52M | +97.6% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 21, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Sep 6, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 30, 2024 | Canaccord Genuity | Maintained | Buy | Buy |
| Aug 9, 2024 | UBS | Maintained | Neutral | Neutral |
| Aug 8, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jun 27, 2024 | Canaccord Genuity | Maintained | Buy | Buy |
| May 10, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 23, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 18, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 14, 2024 | Canaccord Genuity | Maintained | Buy | Buy |
| Mar 13, 2024 | B of A Securities | Maintained | Buy | Buy |
| Feb 21, 2024 | UBS | Downgrade | Buy | Neutral |
| Nov 15, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 31, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 26, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 5, 2023 | Truist Securities | Downgrade | Buy | Hold |
| Sep 13, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 8, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 28, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 23, 2023 | Mizuho | Reiterated | Neutral | Neutral |
| Aug 18, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 15, 2023 | Goldman Sachs | Maintained | Neutral | Neutral |
| Aug 15, 2023 | Mizuho | Downgrade | Buy | Neutral |
| Aug 15, 2023 | Truist Securities | Maintained | Buy | Buy |
| Aug 15, 2023 | Canaccord Genuity | Maintained | Buy | Buy |
| Jul 17, 2023 | Guggenheim | Downgrade | Buy | Neutral |
| Jul 3, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jun 30, 2023 | Mizuho | Reiterated | Buy | Buy |
| May 30, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 26, 2023 | Goldman Sachs | Maintained | Neutral | Neutral |